Ajooni Biotech Limited - Neraca (Quarterly)

Ajooni Biotech Limited
IN ˙ NSEI
Talaan ng Balanse (Quarterly)

Neraca Ajooni Biotech Limited menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2021
03-31
2021
06-30
2021
09-30
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Cash 2 2 17 2 1 2 2 227 3 23 3 14 4 216 170 176 68 157
Change (%) 16.68 603.24 -91.16 -62.18 187.07 10.69 12,363.56 -98.64 648.24 -88.02 390.08 -68.48 4,945.33 -21.23 3.37 -61.17 130.58
Assets Current 187 214 229 214 219 191 195 460 347 347 394 419 323 787 714 751 620 762
Change (%) 14.79 6.84 -6.67 2.62 -12.69 1.84 135.70 -24.55 0.12 13.64 6.26 -22.87 143.31 -9.19 5.08 -17.39 22.96
Assets 248 280 295 288 290 260 274 537 587 544 580 587 475 938 891 937 951 999
Change (%) 12.82 5.11 -2.26 0.77 -10.39 5.40 95.90 9.39 -7.32 6.48 1.22 -19.00 97.46 -5.05 5.13 1.48 5.13
Liabilities 86 124 135 124 126 93 105 144 171 140 172 175 48 83 30 63 70 111
Change (%) 44.53 8.98 -7.95 1.78 -26.41 13.44 36.19 18.77 -18.01 23.22 1.69 -72.55 73.26 -64.36 113.05 10.11 58.70
Equity 163 157 160 164 164 167 169 393 417 404 407 411 427 855 861 873 881 889
Change (%) -3.86 2.06 2.56 0.01 1.97 0.93 133.26 5.96 -2.94 0.69 1.03 3.81 100.19 0.73 1.41 0.85 0.89
Liabilities And Stock Equity 248 280 295 288 290 260 274 537 587 544 580 587 475 938 891 937 951 999
Change (%) 12.82 5.11 -2.26 0.77 -10.39 5.40 95.90 9.39 -7.32 6.48 1.22 -19.00 97.46 -5.05 5.13 1.48 5.13

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista